Purpose: Rupture of the anterior cruciate ligament (ACL) leads to an increased risk of developing knee osteoarthritis (OA). Mechanisms behind this development are not fully understood, and analysis of biomarkers could be used for elucidating these biological processes but also to detect and predict joint pathology and post traumatic OA. We prospectively monitored levels of synovial fluid and serum proinflammatory cytokines and aggrecan ARGS neoepitope, and urine Cterminal type II (CTX-II) and N-terminal type I (NTX-I) collagen telopeptides over five years after ACL rupture. Methods: Synovial fluid, serum and urine were collected from 121 adults at baseline (0-6 weeks after injury),16, 30 and 52 weeks, and two and five years after an acute ACL injury (the KANON trial, ISRCTN 84752559, http://www.controlled-trials.com). Reference samples: synovial fluid (n ¼ 21), serum (n ¼ 23) and urine (n ¼ 62) were from knee healthy volunteers. Synovial fluid and serum concentrations of interleukin (IL)-6, IL-8, IL-10, interferon (IFN)-g, and tumor necrosis factor (TNF)-a were measured by a multiplex immunoassay from Meso Scale Discovery (MSD), and ARGS-aggrecan was analyzed by an in-house immunoassay assay. Urine levels of CTX-II and NTX-I were measured by ELISA assays from IDS and Osteomark, and were corrected for urine creatinine levels (CREP2, Roche). Concentrations of cytokines, ARGS-aggrecan and collagen telopeptides were not normally distributed. We used Mann-Whitney tests for group comparisons and Spearman's rank test (r S ) for correlation analysis. To estimate time until the synovial fluid biomarker concentrations had decreased to half that of the value at baseline ('concentration half-life') a mixed variance components model was used. Results: At baseline (0-6 weeks after injury), synovial fluid cytokine concentrations were elevated 6-(TNF-a, p < 0.001), 7-(IL-8, p < 0.001), 13-(IFN-g, p < 0.001), 21-(IL-10, p < 0.001) and 1050-fold (IL-6, p < 0.001) compared to knee healthy reference levels. This increase was not observed in serum cytokine concentrations. Synovial fluid and serum ARGS-aggrecan, and urine CTX-II concentrations were elevated 8-(p < 0.001), 1.4-(p ¼ 0.002) and 1.5-fold (p ¼ 0.009) respectively, while baseline urine NTX-I levels were no different from the reference. At time periods after baseline, concentrations of synovial fluid cytokines and ARGS-aggrecan, and urine CTX-II and NTX-I decreased rapidly, where ARGS-aggrecan and cytokines showed the following statistically significant mean concentration half-lives, in years: IL-6 0.9, IL-8 2.2, IL-10 2.3, IFN-g 3.1, TNF-a 3.6, ARGS-aggrecan 4.0. Five years after injury, the synovial fluid TNF-a concentration was still higher (1.7-fold, p ¼ 0.044) than the reference level, the urine NTX-I level was lower (0.5-fold, p < 0.001), while the concentration of the other markers were at the same level as seen in references. Over the five year period, there was a correlation between synovial fluid and serum ARGS-aggrecan concentrations (r S ¼ 0.36, p < 0.001), and between serum and synovial fluid ARGS-aggrecan and urine CTX-II levels (r S ¼ 0.36, p < 0.001 and r S ¼ 0.26, p ¼ 0.006, respectively) ( Table 1) . Synovial fluid cytokine concentrations correlated with synovial fluid ARGS-aggrecan level (r S ¼ 0.41 to 0.49, p < 0.001) and with levels of urine collagen telopeptides (r S ¼ 0.21 to 0.31, p ¼ 0.001 to 0.028) ( Table 1) . Conclusions: Acute ACL injury induced high levels of proinflammatory cytokines in the joint which were associated with proteolysis of aggrecan and type II collagen. This trauma induced joint inflammation persisted many years after ACL injury, and together with the reduction of bone turnover, seen several years after injury as decreased urine NTX-I levels, may eventually result in permanent cartilage damage and the development of post traumatic OA. Table 1 Correlation analysis between biomarkers. Spearman's rank order correlation (p-values) between biomarkers in different body fluids from ACL injured subjects (n ¼ 121). To avoid repeated observations, each subject contributed samples at one time point only. Statistically significant correlations are in bold. ARGS, ARGS neoepitope of aggrecan. 
